Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CABOTEGRAVIR vs CALASPARGASE PEGOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CABOTEGRAVIR vs CALASPARGASE PEGOL: Safety Overview

Metric CABOTEGRAVIR CALASPARGASE PEGOL
Total FAERS Reports 8,304 125
Deaths Reported 144 22
Death Rate 1.7% 17.6%
Hospitalizations 428 79
Average Patient Age 41.7 yrs 11.3 yrs
% Female Patients 22.1% 50.0%
FDA Approval Date Dec 20, 2021 N/A
Manufacturer ViiV Healthcare Company Servier Pharmaceuticals LLC
Route ORAL INTRAVENOUS
Marketing Status Prescription N/A